Literature DB >> 20534884

Melatonin signaling and cell protection function.

Francesca Luchetti1, Barbara Canonico, Michele Betti, Marcella Arcangeletti, Francesca Pilolli, Marta Piroddi, Laura Canesi, Stefano Papa, Francesco Galli.   

Abstract

Besides its well-known regulatory role on circadian rhythm, the pineal gland hormone melatonin has other biological functions and a distinct metabolism in various cell types and peripheral tissues. In different tissues and organs, melatonin has been described to act as a paracrine and also as an intracrine and autocrine agent with overall homeostatic functions and pleiotropic effects that include cell protection and prosurvival factor. These latter effects, documented in a number of in vitro and in vivo studies, are sustained through both receptor-dependent and -independent mechanisms that control detoxification and stress response genes, thus conferring protection against a number of xenobiotics and endobiotics produced by acute and chronic noxious stimuli. Redox-sensitive components are included in the cell protection signaling of melatonin and in the resulting transcriptional response that involves the control of NF-κB, AP-1, and Nrf2. By these pathways, melatonin stimulates the expression of antioxidant and detoxification genes, acting in turn as a glutathione system enhancer. A further and converging mechanism of cell protection by this indoleamine described in different models seems to lie in the control of damage and signaling function of mitochondria that involves decreased production of reactive oxygen species and activation of the antiapoptotic and redox-sensitive element Bcl2. Recent evidence suggests that upstream components in this mitochondrial route include the calmodulin pathway with its central role in melatonin signaling and the survival-promoting component of MAPKs, ERK1/2. In this review article, we will discuss these and other molecular aspects of melatonin signaling relevant to cell protection and survival mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534884     DOI: 10.1096/fj.10-154450

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  98 in total

1.  Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Authors:  Thaiz Ferraz Borin; Ali Syed Arbab; Gabriela Bottaro Gelaleti; Lívia Carvalho Ferreira; Marina Gobbe Moschetta; Bruna Victorasso Jardim-Perassi; A S M Iskander; Nadimpalli Ravi S Varma; Adarsh Shankar; Verena Benedick Coimbra; Vanessa Alves Fabri; Juliana Garcia de Oliveira; Debora Aparecida Pires de Campos Zuccari
Journal:  J Pineal Res       Date:  2015-10-20       Impact factor: 13.007

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

3.  The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.

Authors:  Elzbieta Janda; Maddalena Parafati; Serafina Aprigliano; Cristina Carresi; Valeria Visalli; Iolanda Sacco; Domenica Ventrice; Tiziana Mega; Nuria Vadalá; Stefano Rinaldi; Vincenzo Musolino; Ernesto Palma; Santo Gratteri; Domenicantonio Rotiroti; Vincenzo Mollace
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

4.  Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

Authors:  Haibin Lu; Baolei Wu; Ge Ma; Deyu Zheng; Ruijuan Song; Erjiang Huang; Ming Mao; Bin Lu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 5.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

Review 6.  Cellular Timekeeping: It's Redox o'Clock.

Authors:  Nikolay B Milev; Sue-Goo Rhee; Akhilesh B Reddy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

7.  Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells.

Authors:  Tae-Kang Kim; Konrad Kleszczynski; Zorica Janjetovic; Trevor Sweatman; Zongtao Lin; Wei Li; Russel J Reiter; Tobias W Fischer; Andrzej T Slominski
Journal:  FASEB J       Date:  2013-04-25       Impact factor: 5.191

Review 8.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

Review 9.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

10.  Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.

Authors:  Jucimara Colombo; João Marcos Wolf Maciel; Lívia Carvalho Ferreira; Renato Ferreira DA Silva; Debora Aparecida Pires Zuccari
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.